“DOSE OF REALITY”  Calling Big Pharma’s Bluff On PBMs: Part I

Big Pharma has tried to evade culpability for the crisis of rising prescription drug prices by pointing a finger at pharmacy benefit managers (PBMs).  As the U.S. Senate Committee on Finance prepares to hear from the executives of five PBMs on April 9, it’s time to debunk Big Pharma’s bluffs.  PBMs serve an essential role in the prescription drug distribution chain and work on behalf of payers and consumers to reduce prescription drug costs, increase convenience and improve safety.

Ahead of the hearing, we’re setting the record straight on the essential role PBMs play in negotiating savings for patients by calling out Big Pharma’s suspect claims and pushing back on the proposed Rebate Rule’s false promises.

Today, we’re tackling Big Pharma’s claims that PBMs are “unnecessary middlemen.“


PBMs Are Middlemen Who Don’t Add Value To The System.


266 Million Americans Rely On PBMs To Lower The Annual Cost Of Prescription Drugs By Up To 50 Percent.

Though They Now Cast Blame On PBMs, Big Pharma Once Praised Them and Even Solicit Their Services.  

Stay tuned for our next blog tomorrow comparing challenging another one of Big Pharma’s deceptions.

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.